1. |
Details of PDMR/person closely associated with them ('PCA') |
a) |
Name |
Mrs S Jackson |
b) |
Position/status |
SVP, Global Communications & CEO Office |
c) |
Initial notification/ amendment |
Initial notification |
2. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
a) |
Name |
GlaxoSmithKline plc |
b) |
LEI |
5493000HZTVUYLO1D793 |
3. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted |
a) |
Description of the financial instrument |
Ordinary shares of 25 pence each ('Ordinary Shares') ISIN: GB0009252882 |
b) |
Nature of the transaction |
The repurchase of 1,149 Ordinary Shares, at a price of £17.2937, to implement a transfer into an ISA. |
c) |
Price(s) and volume(s) |
Price(s) |
Volume(s) |
£17.2937 |
1,149 |
|
d) |
Aggregated information Aggregated volume Price |
N/A (single transaction) |
e) |
Date of the transaction |
2019-11-08 |
f) |
Place of the transaction |
London Stock Exchange (XLON) |